
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina: Inadvertent anti-VEGF interval increases during the COVID-19 pandemic
2
Dompé enrolls first patients in phase 3 trial of Isocyclosporin for atopic keratoconjunctivitis
3
FLORetina 2025: AI in practice, discussed by Marion Munk and Quan Dong Nguyen
4



